en.Wedoany.com Report on Mar 26th, OYMotion Technologies announced the completion of its Series C1 financing round, raising a total of 150 million yuan. This round was led by the Shenzhen Brain Science and Brain-like Intelligence Industry Investment Fund under CICC Capital, with continued investment from several existing shareholders. The funds will primarily be used for core technology R&D, production capacity expansion, and overseas market development.
Founded in 2015, OYMotion Technologies is one of the early domestic companies to strategically position itself in the two cutting-edge fields of brain-computer interface (BCI) and embodied AI. The company focuses on non-invasive neural signal sensing and AI analysis technology, independently developing core products such as EMG/EEG sensors, intelligent bionic hands, neurorehabilitation exoskeletons, and embodied AI dexterous hands. Unlike invasive brain-computer interfaces, non-invasive solutions collect neural signals from the scalp or skin surface, offering advantages of high safety, wide applicability, and easier large-scale deployment in scenarios like rehabilitation and consumer electronics.
In the field of embodied AI, OYMotion Technologies's ROHand series of dexterous hands has performed particularly well. Jiemian News learned that the product's shipment volume has increased fivefold, covering nearly 100 downstream humanoid robot customers. As the end-effector for humanoid robots to perform tasks, the sensing capability, flexibility, and reliability of dexterous hands directly determine the robot's ability to perform complex operations. By deeply integrating EMG signal analysis technology with robot control algorithms, OYMotion Technologies has endowed its dexterous hands with more precise grasping and manipulation capabilities.
The overseas market has become a significant growth driver for OYMotion Technologies. According to the company, the scale and growth rate of its overseas business have surpassed those of its domestic operations, with products sold to regions including Europe, the United States, the Middle East, and Southeast Asia. This expansion reflects the increasing competitiveness and recognition of China's brain-computer interface and embodied AI technologies in overseas markets.
The lead investor, the Shenzhen Brain Science and Brain-like Intelligence Industry Investment Fund under CICC Capital, is an industry investment fund focused on brain science and brain-like intelligence. Its leadership in this round of investment in OYMotion Technologies demonstrates state-owned capital's confidence in the commercial prospects of the brain-computer interface sector. OYMotion Technologies stated that it will continue to deepen its efforts in both brain-computer interface and embodied AI, promoting the application of neural signal sensing technology in more scenarios such as medical rehabilitation, robot interaction, and consumer electronics.
